Baidu
map

PeerJ:摄入油脂品种换一换,食管癌风险竟能差4倍?4个脂肪酸模式,1种可将ESCC风险翻一番,而另1种却打对折!

2022-04-06 LILYMED MedSci原创

PeerJ:膳食脂肪酸类型与食道鳞状细胞癌的风险

根据《2020年全球癌症统计》,食管癌的发病率居全球第7位,是全球第六大癌症死亡原因。亚洲约占所有食管癌病例的78%,而49%的病例发生在中国。食管癌是中国第六大常见癌症和第四大致命癌症,年龄调整后的5年生存率相对较低,在20-30%之间,超过90%的食管癌病例是食管鳞状细胞癌ESCC

ESCC的发生和预后受多种因素的影响。吸烟、饮酒和环境致癌物暴露是公认的ESCC的主要危险因素。近年来,越来越多的研究强调了营养在这种癌症中的关键作用。在营养因素中,脂肪酸在肿瘤发生中的作用越来越受到关注。目前,一些研究发现脂肪酸与各种癌症的风险密切相关,如肺癌、胰腺癌、结直肠癌和食道癌。

然而,无论是在理论上还是在经验上,由于单一营养或食物方法的局限性,膳食模式评估已成为营养流行病学中测量膳食暴露的一种替代方法。FA模式分析显示了各种脂肪酸之间的相互作用,并解释了它们与疾病的复杂关联。多种脂肪酸的组合比单一脂肪酸对ESCC风险的影响更大。因此,重要的是要考虑脂肪酸的摄入模式。目前,脂肪酸组合与发生ESCC的关联尚未被评估。因此,本研究假设不同的膳食FAPs与ESCC的风险相关,旨在明确特定的膳食FAPs,并研究产生的FAPs与ESCC之间的关系。

共招募了 422 名患者和 423 名对照。将膳食脂肪酸纳入因子分析。多变量逻辑回归和限制三次样条用于评估不同膳食脂肪酸模式(FAPs)对食管癌的特异性风险。在按生活方式暴露因素(吸烟、饮酒、腌制食品、油炸食品、热食、硬食)分层后,应用森林图显示 FAP 与 ESCC 风险之间的关联。

四个主要因子的脂肪酸因子负荷

36种脂肪酸的相关矩阵如图1所示。因子分析,包括36种主要脂肪酸,确定了4个因子,解释了研究人群中这些变量的60.8%的变异。聚类分析也发现了类似的模式。提取4个FA因子评分构建膳食脂肪酸的FAP评分。根据每种模式的主要贡献者(表2),模式1组成主要包括20:0、16:0、11:0、12:0、8:0、18:0、17:0、18:1和20:2,以中链和长链饱和脂肪酸为特征(“MLC-SFA”模式)。模式2的特征是SFAs中从22:6、24:1、20:5、20:1、20:3、20:4和24:0的高正负荷;这被称为" EC-UFA "模式。研究人员将第三种FA模式定性为“SFA模式”,高因子负荷为6:0,10:0, 4:0, 13:0, 14:0和14:1。第四种模式以22:3、22:5、22:4和15:0的高正负荷为特征,称为“n-3 LC-PUFA”模式。

膳食脂肪酸评分与食物组之间的相关性

MLC-SFA 模式评分与“动物油”摄入量呈正相关(r  = 0.124,P  = 0.002)。EC-UFA 模式代表“花生油”含量相对较高的饮食(r  = 0.189,P  < 0.001)。“n-3 LC-PUFA模式”评分与“深海鱼”摄入量呈正相关(r  = 0.099,P  = 0.015)。

脂肪酸模式评分与 ESCC 发病率的关系

根据AIC评估模型拟合性能,模型3的AIC最低,拟合效果最好。在多变量分析中,在调整所有协变量后,n-3 LC-PUFA 模式与较低的 ESCC 可能性相关(OR:0.53, 95% CI [0.34, 0.81],P  = 0.003)。在对潜在的混杂变量进行调整后,EC-UFA 模式与 ESCC 呈正相关(OR:2.07, 95% CI [1.31, 3.26],P  = 0.002)。MLC-SFA 模式和 SFA 模式与 ESCC 无显着相关性(表3)。

膳食脂肪酸评分与ESCC发病率呈线性趋势

四种 FAP 的摄入量与 ESCC 风险之间的剂量反应关系如图2所示。EC-UFA 模式与 ESCC 风险之间存在非线性正相关(非线性p <0.05)。然而,n-3 LC-PUFA 模式与 ESCC 风险之间存在非线性负相关(非线性p <0.001)(图 2)。

膳食脂肪酸模式与ESCC风险的分层分析

图 3表明 FAP 与 ESCC 风险之间的关联按生活方式暴露因素分层。当按油炸食品分层时,MLC-SFA 模式与 ESCC 风险之间的关联是不同的(2 = 75.7%,P异质性 = 0.043)。EC-UFA 模式与 ESCC 风险之间的关联因腌制食品而异(2  = 78.2%,P异质性 = 0.032)。当按吸烟分层时,SFA 模式与 ESCC 风险之间的相关性发生了变化(2  = 99.3%,P异质性<0.001)。此外,此外,在饮酒2  = 91.4%,P异质性 = 0.001)、腌制食品2  = 91.4%,P异质性和油炸食品2  = 93.8%,P异质性<0.001)的人群中,观察到n-3 LC-PUFA模式与ESCC风险之间的关联存在差异。

膳食脂肪酸模式与临床病理因素的相关性

在临床病理特征中,N分期与EC-SFA模式显着相关(s  = 0.270,P  < 0.001)。EC-UFA 模式的摄入量较高可能与晚期疾病的较高风险有关。M 分期与 n-3 LC-PUFA 的模式呈负相关(s  = - 0.175,P  = 0.003)。然而,T 分期与 FAP 没有显着相关性

在这项以医院为基础的病例对照研究中,确定了四种主要的膳食模式,即中长链SFA (MLC-SFA)、偶链不饱和脂肪酸(EC-UFA)、SFA和n-3长链多不饱和脂肪酸(n-3 LC-PUFA)模式。EC-UFA模式与ESCC风险增加相关,而n-3 LC-PUFA模式与风险降低相关。然而,在研究对象中观察到的MLC-SFA或SFA模式没有显著相关性。

这是第一项揭示中国人群膳食 FAP 与 ESCC 风险之间关系的研究。在我们的日常生活中,人们吃的食物是由各种脂肪酸组成的,而不仅仅是一种脂肪酸。因此,FAP分析能够反映实际的膳食质量,并总结各种膳食FAs的作用,具有重要的意义。与分析单一脂肪酸的传统方法相比,因子分析可以调查膳食成分之间的关系。

原文来源:

Hu C, Lin Z, Liu Z, et al. Dietary fatty acid patterns and risk of oesophageal squamous cell carcinoma. PeerJ. 2022;10:e13036. Published 2022 Mar 31. doi:10.7717/peerj.13036.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1729470, encodeId=fc0f1e2947093, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Wed Jul 27 00:34:23 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2062085, encodeId=c06c2062085e7, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Sun Jul 31 07:34:23 CST 2022, time=2022-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1987687, encodeId=7836198e687ed, content=<a href='/topic/show?id=67dd1596982' target=_blank style='color:#2F92EE;'>#SCC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15969, encryptionId=67dd1596982, topicName=SCC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=742793, createdName=zutt, createdTime=Sun May 29 10:34:23 CST 2022, time=2022-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1786936, encodeId=c9021e8693690, content=<a href='/topic/show?id=3bd213998ca' target=_blank style='color:#2F92EE;'>#peer#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13998, encryptionId=3bd213998ca, topicName=peer)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=917c196, createdName=sjzlzc007, createdTime=Sun Jan 15 18:34:23 CST 2023, time=2023-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1437719, encodeId=f49f143e71925, content=<a href='/topic/show?id=0e311010591a' target=_blank style='color:#2F92EE;'>#食管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101059, encryptionId=0e311010591a, topicName=食管)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Thu Apr 07 06:34:23 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1581181, encodeId=447b158118169, content=<a href='/topic/show?id=8a52699e7e' target=_blank style='color:#2F92EE;'>#ESCC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6997, encryptionId=8a52699e7e, topicName=ESCC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53e616746050, createdName=12498b08m95暂无昵称, createdTime=Thu Apr 07 06:34:23 CST 2022, time=2022-04-07, status=1, ipAttribution=)]
    2022-07-27 feather89
  2. [GetPortalCommentsPageByObjectIdResponse(id=1729470, encodeId=fc0f1e2947093, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Wed Jul 27 00:34:23 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2062085, encodeId=c06c2062085e7, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Sun Jul 31 07:34:23 CST 2022, time=2022-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1987687, encodeId=7836198e687ed, content=<a href='/topic/show?id=67dd1596982' target=_blank style='color:#2F92EE;'>#SCC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15969, encryptionId=67dd1596982, topicName=SCC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=742793, createdName=zutt, createdTime=Sun May 29 10:34:23 CST 2022, time=2022-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1786936, encodeId=c9021e8693690, content=<a href='/topic/show?id=3bd213998ca' target=_blank style='color:#2F92EE;'>#peer#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13998, encryptionId=3bd213998ca, topicName=peer)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=917c196, createdName=sjzlzc007, createdTime=Sun Jan 15 18:34:23 CST 2023, time=2023-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1437719, encodeId=f49f143e71925, content=<a href='/topic/show?id=0e311010591a' target=_blank style='color:#2F92EE;'>#食管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101059, encryptionId=0e311010591a, topicName=食管)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Thu Apr 07 06:34:23 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1581181, encodeId=447b158118169, content=<a href='/topic/show?id=8a52699e7e' target=_blank style='color:#2F92EE;'>#ESCC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6997, encryptionId=8a52699e7e, topicName=ESCC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53e616746050, createdName=12498b08m95暂无昵称, createdTime=Thu Apr 07 06:34:23 CST 2022, time=2022-04-07, status=1, ipAttribution=)]
    2022-07-31 sjq027
  3. [GetPortalCommentsPageByObjectIdResponse(id=1729470, encodeId=fc0f1e2947093, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Wed Jul 27 00:34:23 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2062085, encodeId=c06c2062085e7, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Sun Jul 31 07:34:23 CST 2022, time=2022-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1987687, encodeId=7836198e687ed, content=<a href='/topic/show?id=67dd1596982' target=_blank style='color:#2F92EE;'>#SCC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15969, encryptionId=67dd1596982, topicName=SCC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=742793, createdName=zutt, createdTime=Sun May 29 10:34:23 CST 2022, time=2022-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1786936, encodeId=c9021e8693690, content=<a href='/topic/show?id=3bd213998ca' target=_blank style='color:#2F92EE;'>#peer#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13998, encryptionId=3bd213998ca, topicName=peer)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=917c196, createdName=sjzlzc007, createdTime=Sun Jan 15 18:34:23 CST 2023, time=2023-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1437719, encodeId=f49f143e71925, content=<a href='/topic/show?id=0e311010591a' target=_blank style='color:#2F92EE;'>#食管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101059, encryptionId=0e311010591a, topicName=食管)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Thu Apr 07 06:34:23 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1581181, encodeId=447b158118169, content=<a href='/topic/show?id=8a52699e7e' target=_blank style='color:#2F92EE;'>#ESCC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6997, encryptionId=8a52699e7e, topicName=ESCC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53e616746050, createdName=12498b08m95暂无昵称, createdTime=Thu Apr 07 06:34:23 CST 2022, time=2022-04-07, status=1, ipAttribution=)]
    2022-05-29 zutt
  4. [GetPortalCommentsPageByObjectIdResponse(id=1729470, encodeId=fc0f1e2947093, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Wed Jul 27 00:34:23 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2062085, encodeId=c06c2062085e7, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Sun Jul 31 07:34:23 CST 2022, time=2022-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1987687, encodeId=7836198e687ed, content=<a href='/topic/show?id=67dd1596982' target=_blank style='color:#2F92EE;'>#SCC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15969, encryptionId=67dd1596982, topicName=SCC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=742793, createdName=zutt, createdTime=Sun May 29 10:34:23 CST 2022, time=2022-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1786936, encodeId=c9021e8693690, content=<a href='/topic/show?id=3bd213998ca' target=_blank style='color:#2F92EE;'>#peer#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13998, encryptionId=3bd213998ca, topicName=peer)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=917c196, createdName=sjzlzc007, createdTime=Sun Jan 15 18:34:23 CST 2023, time=2023-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1437719, encodeId=f49f143e71925, content=<a href='/topic/show?id=0e311010591a' target=_blank style='color:#2F92EE;'>#食管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101059, encryptionId=0e311010591a, topicName=食管)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Thu Apr 07 06:34:23 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1581181, encodeId=447b158118169, content=<a href='/topic/show?id=8a52699e7e' target=_blank style='color:#2F92EE;'>#ESCC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6997, encryptionId=8a52699e7e, topicName=ESCC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53e616746050, createdName=12498b08m95暂无昵称, createdTime=Thu Apr 07 06:34:23 CST 2022, time=2022-04-07, status=1, ipAttribution=)]
    2023-01-15 sjzlzc007
  5. [GetPortalCommentsPageByObjectIdResponse(id=1729470, encodeId=fc0f1e2947093, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Wed Jul 27 00:34:23 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2062085, encodeId=c06c2062085e7, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Sun Jul 31 07:34:23 CST 2022, time=2022-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1987687, encodeId=7836198e687ed, content=<a href='/topic/show?id=67dd1596982' target=_blank style='color:#2F92EE;'>#SCC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15969, encryptionId=67dd1596982, topicName=SCC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=742793, createdName=zutt, createdTime=Sun May 29 10:34:23 CST 2022, time=2022-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1786936, encodeId=c9021e8693690, content=<a href='/topic/show?id=3bd213998ca' target=_blank style='color:#2F92EE;'>#peer#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13998, encryptionId=3bd213998ca, topicName=peer)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=917c196, createdName=sjzlzc007, createdTime=Sun Jan 15 18:34:23 CST 2023, time=2023-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1437719, encodeId=f49f143e71925, content=<a href='/topic/show?id=0e311010591a' target=_blank style='color:#2F92EE;'>#食管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101059, encryptionId=0e311010591a, topicName=食管)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Thu Apr 07 06:34:23 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1581181, encodeId=447b158118169, content=<a href='/topic/show?id=8a52699e7e' target=_blank style='color:#2F92EE;'>#ESCC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6997, encryptionId=8a52699e7e, topicName=ESCC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53e616746050, createdName=12498b08m95暂无昵称, createdTime=Thu Apr 07 06:34:23 CST 2022, time=2022-04-07, status=1, ipAttribution=)]
    2022-04-07 zhouqu_8
  6. [GetPortalCommentsPageByObjectIdResponse(id=1729470, encodeId=fc0f1e2947093, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Wed Jul 27 00:34:23 CST 2022, time=2022-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2062085, encodeId=c06c2062085e7, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Sun Jul 31 07:34:23 CST 2022, time=2022-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1987687, encodeId=7836198e687ed, content=<a href='/topic/show?id=67dd1596982' target=_blank style='color:#2F92EE;'>#SCC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15969, encryptionId=67dd1596982, topicName=SCC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=742793, createdName=zutt, createdTime=Sun May 29 10:34:23 CST 2022, time=2022-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1786936, encodeId=c9021e8693690, content=<a href='/topic/show?id=3bd213998ca' target=_blank style='color:#2F92EE;'>#peer#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13998, encryptionId=3bd213998ca, topicName=peer)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=917c196, createdName=sjzlzc007, createdTime=Sun Jan 15 18:34:23 CST 2023, time=2023-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1437719, encodeId=f49f143e71925, content=<a href='/topic/show?id=0e311010591a' target=_blank style='color:#2F92EE;'>#食管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101059, encryptionId=0e311010591a, topicName=食管)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Thu Apr 07 06:34:23 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1581181, encodeId=447b158118169, content=<a href='/topic/show?id=8a52699e7e' target=_blank style='color:#2F92EE;'>#ESCC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6997, encryptionId=8a52699e7e, topicName=ESCC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53e616746050, createdName=12498b08m95暂无昵称, createdTime=Thu Apr 07 06:34:23 CST 2022, time=2022-04-07, status=1, ipAttribution=)]

相关资讯

Nat Commun:食管鳞状细胞癌中诱导化疗结合根治性放化疗与单独放化疗的疗效比较

食管癌(EC)作为全球癌症相关死亡的第六大原因,是一种预后不佳的致命性疾病。

Cell Death Differ:PIWIL2通过与IKK相互作用调节食管鳞状细胞癌细胞自噬和凋亡的发生

食道癌作为全球第八大最普遍的癌症类型,也是第六大癌症相关死亡的主要原因。食道腺癌(EAC)和食道鳞状细胞癌(ESCC)是食管癌的两种常见组织学亚型。ESCC在包括中国在内的东亚地区更为普遍(>9

Jpn J Clin Oncol:研究人员在晚期食管鳞状细胞癌患者血清中发现了能够预测对nivolumab反应的候选miRNAs

Nivolumab是一种程序性细胞死亡蛋白1(PD-1)抑制剂,在一项II期研究中显示出治疗晚期食管鳞状细胞癌的良好活性(ONO-4538-07;JapicCTI-No.142422)。本研究中,我们

Nat Genet:食管鳞状细胞癌的突变特征研究

食管癌作为全球第六大最常见的癌症相关死亡原因,食管鳞状细胞癌(ESCC)是其最常见的一种亚型。

Br J Cancer:人群队列研究揭示更年期激素治疗可降低食管腺癌患病风险

在过去的40年里,西方国家中包括贲门腺癌在内的食管腺癌的发病率迅速上升,而另一类主要组织学类型的食管癌——食管鳞状细胞癌的发病率则有所下降。

Cell Death Dis:高表达水平DHODH介导β-catenin的稳定促进食管鳞状细胞癌的发生发展

食管鳞状细胞癌(ESCC)作为全球癌症相关死亡的第九大原因,每年有超过515,000例新发病例。其中,中国的ESCC发病率和死亡率最高,高达70%。由于早期诊断的缺乏、有限的治疗选择和频繁的疾病复发,

Baidu
map
Baidu
map
Baidu
map